Company

Towa Pharmaceutical Co. Ltd

Headquarters: Osaka, Japan

Employees: 3,456

JPX: 4553 -1.13%

Market Cap

¥143.50 Billion

JPY as of Jan. 1, 2025

US$914.5 Million

Market Cap History

Towa Pharmaceutical Co. Ltd Categories

Japan Healthcare Drug Manufacturers—Specialty & Generic
Japan Healthcare Japan Drug Manufacturers—Specialty & Generic

Towa Pharmaceutical Co. Ltd market capitalization over time

Evolution of Towa Pharmaceutical Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Towa Pharmaceutical Co. Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $75.33 B
MERCK Kommanditgesellschaft auf Aktien $65.17 B
Haleon plc $42.16 B
Takeda Pharmaceutical Company Limited $41.47 B
Teva Pharmaceutical Industries Limited $18.95 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.

Stocks & Indices

Towa Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: JPX: 4553 wb_incandescent

Stock: FSX: 6QC wb_incandescent

Details

Headquarters:

2-11, Shinbashi-cho

Kadoma

Osaka, 571-8580

Japan

Phone: 81 6 6900 9100

Fax: 81 6 6908 2138